A study published by the Journal of Clinical Pharmacy and Therapeutics has found that cannabidiol (CBD), a compound found in cannabis, can control the symptoms of REM sleep behavior disorder (RBD) in those with Parkinson’s disease. “Cannabidiol (CBD) is the main non-psychotropic component of the Cannabis sativa plant”, explains researchers. “REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep associated with nightmares and active behaviour during dreaming. We have described the effects of CBD in RBD symptoms in patients with Parkinson’s disease.” During the study; “Four patients treated with CBD had…
Author: WebTeam
First Lady is a pure Afghani seed-strain offering the uniformity and rich flavour of old-time cultivars backed up with the vigour and punch of modern hybrid cannabis. This strain’s direct ancestors originate in Afghanistan and Pakistan, in the high-altitude passes and lower steppes of the Hindu Kush, between Chitral and Kandahar. The prized Cannabis Afghanica strains of these neighbouring regions share very similar genotypes and strong Indica growth patterns, having been selected over years or centuries to enhance the qualities prized in traditional hashish production – resin content, stocky growth and quick, heavy flowering. First Lady is thus more like…
Extremely low doses of the cannabis compound delta-9-tetrahydrocannabinol (THC) may slow or even halt entirely the progression of Alzheimer’s disease, a new study from neuroscientists at the University of South Florida (USF) shows. Findings from the research were reported online in the Journal of Alzheimer’s Disease. For the study, researchers from the USF Health Byrd Alzheimer’s Institute showed that extremely low doses of THC reduced the production of amyloid beta (which is found in a soluble form in most aging brains), and prevented abnormal accumulation of this protein – a process considered to be one of the pathological hallmarks in…
A study published recently in the Journal of Clinical Investigation and the National Institute of Health has found that the cannabis compound cannabidiol, often referred to simply as CBD, may provide a potential treatment for acne. For the study, researchers used cannabidiol derived from cannabis on human sebaceous gland function, and determined that CBD behaves as a highly effective sebostatic agent. “Administration of CBD to cultured human sebocytes and human skin organ culture inhibited the lipogenic actions of various compounds, including arachidonic acid and a combination of linoleic acid and testosterone, and suppressed sebocyte proliferation via the activation of transient…
A new study out of Finland, published by the U.S. National Institute of Health and the journal Duodecim, has found that cannabis significantly improved the quality of life for a patient with cerebral palsy. “Cannabinoid was licensed in 2012 for the treatment of spasticity associated with multiple sclerosis in Finland”, states the study. “Spasticity is one of the main symptoms in cerebral palsies and a risk factor of multiple painful anomalies of the skeletal network. We describe a 28-year-old man with severe cerebral palsy, whose quality of life improved and the need for help decreased by using two daily mouth…
August 26, 2014 | The use of alcohol significantly increases one’s likelihood of becoming either a perpetrator or a victim of a violent act, including acts of intimate partner violence. As for cannabis use — that’s a different story. In fact, according to a just-published study in the journal Psychology and Addictive Behaviors, couples who use pot are particularly unlikely to engage in intimate partner violence. Investigators at Yale University, Rutgers, and the University of Buffalo assessed over 600 couples to determine whether husbands’ and wives’ pot use was predictive of domestic abuse at any time during the first nine years of…
A new study has found evidence that cannabis may help treat osteoporosis, specifically in men suffering from prostate disease. According to researchers from Konkuk University, in Seoul, Republic of Korea, a substantial portion of men with prostatic disease have an increased risk of bone loss, but activating cannabinoid receptors can help combat these effects. Scientists induced prostatic hyperplasia (enlargement of the prostate gland) in rats and administered a cannabinoid agonist. The enhanced cannabinoid receptor expression caused an upregulation of osteoblastogenesis, or an increase in bone growth, while inhibiting the prostatic hyperplasia. Researchers conclude that these results suggest activated cannabinoid receptors…
The administration of a single dose of whole-plant cannabis via a thermal-metered inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy. Israeli investigators assessed the efficacy of a novel, portable metered-dose cannabis inhaler in eight subjects diagnosed with chronic neuropathic pain. Researchers reported that the device administered an efficient, consistent, and therapeutically effective dosage of cannabinoids to all participants. They concluded, “This trial suggests the potential use of the Syqe Inhaler device as a smokeless delivery…
A new study being published in the upcoming issue of the journal BMC Musculoskeletal Disorders, and e-published ahead of print by the National Institute of health, has found that a cannabinoid receptor agonist can successfully help against some of the primary symptoms of rheumatoid arthritis (RA), indicating that cannabis, which is a natural agonist to the body’s cannabinoid receptors, may provide a treatment option for the condition. For the study, mice with RA were injected with JWH133, a selective CB2 [cannabinoid receptor type 2] agonist, and it was found that it “reduced the arthritis score, inflammatory cell infiltration, bone destruction,…
A study published this month in the journal Neuropharmacology, and published online by the U.S. National Institute of Health, has found that prolonged administration of a compound meant to mimic the effects of cannabis can improve motor symptoms and stimulate neuroprotective processes in those with Huntington’s disease. “Huntington’s disease (HD) is a devastating neurodegenerative disease characterized by a progressive decline in motor abilities, as well as in cognitive and social behaviors”, claims the study. “Most of these behavioral deficits are recapitulated in the R6/1 transgenic mouse, which can therefore be used as an experimental model to identify the neurobiological substrates…
